Daily Activity and Gait Analysis After Viscosupplement Injection Among Hip Osteoarthritis Patients

• Status: Completed
• Trial end date: 2017-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to assess the changes in daily physical activity and gait pattern, following a viscosupplement injection among a population who is suffering from hip osteoarthritis. A kinetic and kinematic gait analysis, an Actigraph activity monitor, a functional Timed-Stair-Test and two questionnaires (Medical Outcome Study Short-Form36 (MOS-SF36), Hip disability and Osteoarthritis Outcome Score (HOOS)) about how the pathology affects the quality of life, will be use.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Laval University
• Treatments: Bupivacaine; Hyaluronic Acid; Viscosupplements

Criteria

Inclusion Criteria:

• From 45 years old to 65 years old

• Clinically symptomatic moderate or severe hip osteoarthritis (Tönnis Grade II to III)

• Capacity to keep steady upright position and walking during 15 minutes

• Body mass index < 40kg/m2

Exclusion Criteria:

• Bilateral hip osteoarthritis

• No broken hip or leg during the last 12 months

• Bone necrosis

• Rheumatoid arthritis, articular chondrocalcinosis, metabolic bone disease, psoriasis, gout, active infection

• Per os corticosteroid treatment

• Corticosteroid injection < 3 months

• Viscosupplement injection < 6 months

• Hypersensitivity to hyaluronic acid products

• Planed surgery during study duration

• Physical or mental disability to fill in questionnaires and/or to participate to follow-up